Johnson & Johnson vs Peloton Interactive Inc — how do they compare? Johnson & Johnson trades at $261.43 (market cap $618.09B), while Peloton Interactive Inc trades at $5.11 (market cap $2.16B). The key difference: Johnson & Johnson is far larger — about 286.2× Peloton Interactive Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Peloton Interactive Inc for 37 Days on average.
| JNJ | PTON | |
|---|---|---|
Market Cap | $618.09B | $2.16B |
Volume | 6,050,983 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $278.43 | $7.86 |
52-Week Low | $186.00 | $3.71 |
Typical Hold Time | 129 Days | 37 Days |
Enterprise Value | $646.37B | $2.66B |
Dividend Yield | 2.09% | — |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
Peloton Interactive (PTON) trades at $5.12, up 5.57% today, as the company shows signs of a turnaround with its first profitable year in 2026. Technical indicators remain bearish overall, while fundamentals reveal improving profitability with net income margin turning positive at 2.58%. Recent product launches including the foldable Tread Flex and AI-powered coaching features aim to broaden market appeal. The stock trades well below analyst consensus price target of $8.00, with 50% of analysts maintaining buy ratings despite recent insider selling activity.
PTON presents a turnaround story with improving financial metrics but faces execution risks amid declining subscriber counts. The company's debt-heavy balance sheet and negative shareholder equity remain concerns, though cash flow improvements and cost-cutting measures show progress. Upside potential exists if new product adoption drives subscriber growth, but competition and macroeconomic pressures create headwinds for sustained recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →